{
    "organizations": [],
    "uuid": "d2c2f76490e6d2092a7c761aa8de7a6ce2f1a681",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncobiologics-q2-loss-per-share-03/brief-oncobiologics-q2-loss-per-share-0-34-idUSASC0A2FT",
    "ord_in_thread": 0,
    "title": "BRIEF-Oncobiologics Q2 Loss Per Share $0.34",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Oncobiologics Inc:\n* ONCOBIOLOGICS REPORTS SECOND QUARTER FINANCIAL RESULTS FOR FISCAL 2018\n* Q2 LOSS PER SHARE $0.34 * AT MARCH 31, 2018, COMPANY HAD CASH OF $5.9 MILLION, COMPARED TO $3.2 MILLION AT SEPTEMBER 30, 2017 Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-16T04:20:00.000+03:00",
    "crawled": "2018-05-16T18:56:41.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "oncobiologics",
        "inc",
        "oncobiologics",
        "report",
        "second",
        "quarter",
        "financial",
        "result",
        "fiscal",
        "q2",
        "loss",
        "per",
        "share",
        "march",
        "company",
        "cash",
        "million",
        "compared",
        "million",
        "september",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}